Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of December 2025
Key Event: The registrant issued a press release on December 26, 2025, announcing the granting of a Brazilian patent for the treatment of sexual dysfunction.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to incorporate a press release by reference and does not contain financial statements or quantitative financial data.
Material Changes
Intellectual Property: Can-Fite Biopharma Ltd. was granted a patent in Brazil for the treatment of sexual dysfunction. This represents a material development in the company's intellectual property portfolio and potential market access in Brazil.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary on financial performance, or a discussion of risks and contingencies beyond the announcement of the patent grant. The document incorporates the press release (Exhibit 99.1) into existing Registration Statements on Forms S-8 and F-3.
Key Facts for Investor Verification
- Verify the specific scope and claims of the Brazilian patent granted for the treatment of sexual dysfunction.
- Review the full text of the press release (Exhibit 99.1) for details on commercialization plans or regulatory implications in Brazil.
- Confirm the status of the company's other intellectual property portfolios and pipeline developments not covered in this specific filing.